The performance of our urine oxalate method on an external quality assessment scheme [Randox International Quality Assessment Scheme (RIQAS), Randox] showed a poorer than expected precision (variability of bias of 21´0%), with a negative bias against our method group mean (oxalate oxidase) for a number of samples. This negative bias was more apparent at low levels. We used the standard Sigma (Sigma-Aldrich, Poole, Dorset, UK) assay 1 with the recommended protocol for the MIRA S analyser. For internal quality control (QC) we used normal and elevated Sigma QC material that gave values within the target range quoted FIGURE 1. Oxalate reaction course, showing effect of carry-over and effect of increasing preincubation time.
by the manufacturer and acceptable precision (CVs of 8´9±11´0%), although the normal QC had a negative bias.
The Sigma method involves manual charcoal extraction of oxalate before the automated assay. After a short incubation with reagent A containing oxalate oxidase, the liberated hydrogen peroxide is reacted with colour reagent B (3methyl-2-benzothiozolinone and 3-(dimethylamino)benzoic acid). The difference between the ®nal absorbance and that immediately prior to the addition of the second reagent is used to calculate the oxalate concentration.
Examination of the raw absorbance data at 590 nm ( Fig. 1) showed that for some of the cuvettes the absorbance started rising before the addition of colour reagent B, indicating partial starting of the colour development phase of the reaction. On the MIRA the sample probe is used to add both sample and start reagent in separate steps to the reaction cuvettes. The data suggested that the MIRA sample probe was not washed thoroughly enough between reagent pipetting steps to eliminate the carry-over of colour reagent.
Cleaning the wash station made only a marginal improvement in this situation, and further maintenance work by the manufacturer (Roche) only produced another small improvement. The performance of our reagents on a MIRA analyser at another hospital showed a similar but more marked effect.
Further evaluation of the results demonstrated that every third result showed signi®cant carryover, with the reaction starting early. In the reagent addition schedule used by the MIRA the addition of enzyme reagent for cuvettes 4, 7, 10, etc. is immediately preceded by colour reagent. It was the carry-over of this reagent that caused the increased absorbance during the incubation with enzyme, and hence a lowered measured absorbance change between time point 3 and the end of the assay. Our low internal QC sample was always in position 4, which explains the negative bias. The external quality assessment sample would either be unaffected or signi®cantly low.
As the sample probe washing could not be signi®cantly improved, we overcame this problem by delaying the injection of colour reagent B, changing it from cycle 4 to cycle 20. This allowed 20 samples and the associated enzyme reagents to be pipetted before any colour reagent contaminated the probe. This arrangement was more than adequate for our normal workload.
Starting the reaction later has no disadvantages for the chemistry of the reaction and could have a minor bene®cial effect, allowing a longer time for the release of hydrogen peroxide by oxalate oxidase during the ®rst phase of the reaction. This had the desired effect of preventing the early start of reactions and solving the problems we had been experiencing in the Randox RIQAS programme (Fig. 2) . The variability of the bias against the target value dropped to 6´6%. In addition, the betweenbatch internal QC imprecision improved to 4´6% at 0´3 mmol/l and 2´2% at 1´0 mmol/l.
Because this method appears to be very sensitive to sample probe contamination by colour reagent B carry-over, and the amount of carry-over is variable from analyser to analyser, we feel users should consider a modi®cation to the standard protocol, either by increasing the preincubation time or by introducing an extra wash between pipettings to reduce the problem. 
